investment

News

As Trump visits UK, GSK pledges $30bn in US investment

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

News

AZ halts UK investment, and Lilly, Sanofi follow suit

After MSD's bombshell retreat from a big UK investment plan, AstraZeneca, Lilly, and Sanofi are also pressing pause on new projects.

News

Reaction to MSD's UK exit as government tries to renew talks

The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap a £1bn investment spend.

News

Pharma says UK is 'tumbling down' rankings for investment

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects, says a report from the ABPI pharma group.

News

Fresh blow to UK life sciences as MSD abandons £1bn project

In a blow to UK life science ambitions, MSD has scrapped a £1bn expansion of its operations in the country, saying it does not value innovation.

News

Gilead, Amgen kick off facility investments in US

This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.

As Trump visits UK, GSK pledges $30bn in US investment

AZ halts UK investment, and Lilly, Sanofi follow suit

Reaction to MSD's UK exit as government tries to renew talks

Pharma says UK is 'tumbling down' rankings for investment

Fresh blow to UK life sciences as MSD abandons £1bn project

Gilead, Amgen kick off facility investments in US

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

investment

Editor's Picks